drugset / Trial / NCT00583453

Celecoxib as a Post-tonsillectomy Pain Medication

NCT00583453

Phase 2 Completed 18 enrolled University of Iowa Pfizer · collab
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The hypothesis is that celecoxib effectively reduces pain after a tonsillectomy and reduces post-operative narcotic use. To test this hypothesis, the study is placebo controlled (sugar pill). Half of the participants will receive a sugar pill, half will not. All participants will receive the standard post-operative pain medications. We ask participants to log the amount of medications they use daily, and the amount of pain they have each day. It is hoped that celecoxib will reduce the amount of post-operative pain medication needed.

Timeline

Start
2007-10
Primary completion
2013-12
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg

Indications